A detailed history of Laraway Financial Advisors Inc transactions in Novartis Ag stock. As of the latest transaction made, Laraway Financial Advisors Inc holds 2,467 shares of NVS stock, worth $272,652. This represents 0.22% of its overall portfolio holdings.

Number of Shares
2,467
Previous 2,467 -0.0%
Holding current value
$272,652
Previous $238,000 10.08%
% of portfolio
0.22%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023

SELL
$92.52 - $104.91 $13,878 - $15,736
-150 Reduced 5.73%
2,467 $248,000
Q1 2023

Jun 09, 2023

SELL
$80.03 - $92.81 $12,004 - $13,921
-150 Reduced 5.42%
2,617 $240,000
Q4 2022

Feb 22, 2023

SELL
$75.55 - $92.52 $226 - $277
-3 Reduced 0.11%
2,767 $251,000
Q4 2021

Feb 11, 2022

BUY
$79.7 - $88.13 $220,769 - $244,120
2,770 New
2,770 $242,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Laraway Financial Advisors Inc Portfolio

Follow Laraway Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laraway Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Laraway Financial Advisors Inc with notifications on news.